Deplorable is not Phenomenal

[markado]

Mike needs to grab MNKD's narrative by the horns. He also needs to deliver on event-based news with regularity, accuracy, if not precision. Where's the CIPLA India data? Where's the Blue-Hale launch? How about 100% enrollment in the Peds trial? We shouldn't have to wait quarter to quarter or conference to conference for news drops. It's a very lazy and laissez-faire way of (not) communicating the vision and momentum of the business. There's nothing wrong with MNKD being a bit more of a momentum stock to unlock SHV!

[cjm18]

Jun 20, 2023 10:27:19 GMT -5 markado said:

Mike needs to grab MNKD's narrative by the horns. He also needs to deliver on event-based news with regularity, accuracy, if not precision. Where's the CIPLA India data? Where's the Blue-Hale launch? How about 100% enrollment in the Peds trial? We shouldn't have to wait quarter to quarter or conference to conference for news drops. It's a very lazy and laissez-faire way of (not) communicating the vision and momentum of the business. There's nothing wrong with MNKD being a bit more of a momentum stock to unlock SHV!

Unlock shv?

[lennymnkd]

Shareholder value ?

[porkini]

SHV

I know, I know, it is probably "share holder value" 

[markado]

SHV - my attempt to abbreviate shareholder value...

As always diamond hands and GLTAL's!

[prcgorman2]

I've worked in small companies that had very active social marketing to keep "messaging" fresh and updated. The messaging was designed to return SHV (Share Holder Value) by encouraging customers to be engaged and make purchases driving revenue.

What you're asking for though is information that drives investment. Marketing to investors IS what is in the updates we hear or see in the investor conferences that Mike attends (and that naysayers question and mock as being not valuable). I think the proof of that marketing is that the majority shareholders are institutional investors (the ones at those conferences) and not retail investors who show up on boards like this one. Prior to Mike's tenure, retail investors were the primrary shareholders. You know, back when MNKD was selling for 80 cents a share instead of 5x that.

Could MNKD investor marketing be more successful? Of course, but what other company of a similar size, maturity, and in a similar business should we compare it to so that we have an appropriate benchmark? And what do those institutional investors we want marketed to want to see? What should that messaging look like? My opinion is it should be quarterly fundamentals showing solid (and if possible double-digit or more) revenue growth. That doesn't need frequent marketing messaging. In fact, I'll argue quarterly IS frequent messaging if the audience you care about is institutional investors.

We've mentioned before that DTC marketing fell flat and agedhippie, stevil, matt, and others have said time and again it's because the persons with diabetes are not motivated to argue with their care provider, and their care provider isn't motivated by DTC. What motivates the prescribers is data, and that comes from studies, and those are expensive and take time. And frequent updates on something that takes a long time might frankly look repetitive and uninspiring. Ever work on long drawn-out projects lasting months or even years, and then gone to daily update meetings?

We need data, we need revenue, and both of those are on the way. How's that for an update?

[LongMNKD]

MNKD moves at a slugs pace. not even diamond hands can grip a slug!

[prcgorman2]

Jun 20, 2023 15:20:48 GMT -5 LongMNKD said:

MNKD moves at a slugs pace. not even diamond hands can grip a slug!

Wait, you are saying you do not like slime?  I'm confused.

[lennymnkd]

Disagree on the DTC ADD .. add wasn’t effective on its own merit…we’re an FDA approved drug 
with subjective convenience not seen before in diabetes… a DEXCOM STYLE ADD WOULD HAVE MADE ALL THE 
DIFFERENCE IN THE WORLD ..and still will .. watch the Dexcom add and insert Afrezza .

[cretin11]

The ad was poorly executed, nobody can reasonably dispute that. Would a good or even halfway decent ad have made a difference? We can't know the answer to that, we can only speculate. (Cue some apologist saying "the FDA makes it impossible to create a good ad" or "that ad won an award" or "flying hamburgers was a brilliant idea that somehow did not convince people.")

As for SHV, it's no wonder folks on a MNKD message board would have difficulty deciphering that acronym, it's an unfamiliar concept!

[markado]

Jun 20, 2023 14:58:58 GMT -5 prcgorman2 said:

I've worked in small companies that had very active social marketing to keep "messaging" fresh and updated. The messaging was designed to return SHV (Share Holder Value) by encouraging customers to be engaged and make purchases driving revenue.

What you're asking for though is information that drives investment. Marketing to investors IS what is in the updates we hear or see in the investor conferences that Mike attends (and that naysayers question and mock as being not valuable). I think the proof of that marketing is that the majority shareholders are institutional investors (the ones at those conferences) and not retail investors who show up on boards like this one. Prior to Mike's tenure, retail investors were the primrary shareholders. You know, back when MNKD was selling for 80 cents a share instead of 5x that.

Could MNKD investor marketing be more successful? Of course, but what other company of a similar size, maturity, and in a similar business should we compare it to so that we have an appropriate benchmark? And what do those institutional investors we want marketed to want to see? What should that messaging look like? My opinion is it should be quarterly fundamentals showing solid (and if possible double-digit or more) revenue growth. That doesn't need frequent marketing messaging. In fact, I'll argue quarterly IS frequent messaging if the audience you care about is institutional investors.

We've mentioned before that DTC marketing fell flat and agedhippie, stevil, matt, and others have said time and again it's because the persons with diabetes are not motivated to argue with their care provider, and their care provider isn't motivated by DTC. What motivates the prescribers is data, and that comes from studies, and those are expensive and take time. And frequent updates on something that takes a long time might frankly look repetitive and uninspiring. Ever work on long drawn-out projects lasting months or even years, and then gone to daily update meetings?

We need data, we need revenue, and both of those are on the way. How's that for an update?

Does Martine only deliver news as regulated by the SEC? The point about controlling the narrative is keeping momentum going between expected reporting cycles. It also demonstrates a CEO understands the importance of talking to the market and has the ability to control their agenda enough to deliver on the in betweens. Mike doesn't seem to care to cater to the upside cycles of the market. He seems content to just let things play out. That's not quite all that I as an investor expect of a CEO. To each their own.

[awesomo]

After the good earnings call, MannKind has done the complete opposite of keeping the momentum going.

[peppy]

deplorable; deserving strong condemnation.
Similar:
disgraceful
shameful
dishonorable
disreputable
discreditable

phenomenal
very remarkable; extraordinary.
Similar:
exceptional
extraordinary
remarkable
outstanding
amazing

markado, please tell me how EXACTLY, what would you do? What is your phenomenal plan?
be specific and legal please.

Deplorable, strange word search.

[castlerockchris]

The topic of this thread is the exact reason I stopped working as head of marketing for public companies about half way through my career. Shareholders have put too much emphasis on short term expectations (particularly tied to stock price) that don’t always align with the market place realities, or the company’s for that matter. Wasn’t it just a week or so ago that Mike had the governor of the state of Connecticut at MNKD’s facility announcing a massive increase in manufacturing capacity to meet the T-DPI demand? What was the impact on SHV? As a long time shareholder, I want Mike focused on delivering product that will deliver sustained revenue growth, not pumping the PR machine. PR for PR sake does not create sustainable shareholder value (buy the rumor, sell on the news?). I continue to be focused one to two years out when it comes to my investment in MNKD. The PR will come when there is something to blow the horn about, then it had better be really loud. Until then I will pass on the thousand press releases about little progress items, cause when the time comes to be loud, people will just shrug it off as simply another announcement from MNKD.

[markado]

Jun 20, 2023 18:00:30 GMT -5 castlerockchris said:

The topic of this thread is the exact reason I stopped working as head of marketing for public companies about half way through my career. Shareholders have put too much emphasis on short term expectations (particularly tied to stock price) that don’t always align with the market place realities, or the company’s for that matter. Wasn’t it just a week or so ago that Mike had the governor of the state of Connecticut at MNKD’s facility announcing a massive increase in manufacturing capacity to meet the T-DPI demand? What was the impact on SHV? As a long time shareholder, I want Mike focused on delivering product that will deliver sustained revenue growth, not pumping the PR machine. PR for PR sake does not create sustainable shareholder value (buy the rumor, sell on the news?). I continue to be focused one to two years out when it comes to my investment in MNKD. The PR will come when there is something to blow the horn about, then it had better be really loud. Until then I will pass on the thousand press releases about little progress items, cause when the time comes to be loud, people will just shrug it off as simply another announcement from MNKD.

As a shareholder 8 years running, with over 50k shares, I'm not concerned with every short term news bit. I am concerned that we go dark all too often. We over promise and under deliver equally as often. Mike simply doesn't present as being in control of the company's narrative, which is interpreted by the market as the company's direction. If he wants credit for executing on a vision, then he needs to share that vision ahead of delivery (the what, why and when) and then deliver on it. The recent mention of the delivery of Cipla data in a week or so, with a failure to deliver on it makes him look at best under-informed, at worst out of synch with their on the ground realities. Same for the Blue-Hale launch. At $4 a share you're damn right I'm a frustrated long, and no, I really don't want to wait another two years just hoping it will all work out.